We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Parasitic Worm Consumes Female Reproductive Organs

By LabMedica International staff writers
Posted on 16 Nov 2010
A parasitic helminth eats its way into the female internal reproductive organs inflicting considerable damage, and making them particularly vulnerable to infection. More...


The parasitic disease, commonly known as snail fever, or schistosomiasis, which is transmitted via parasites in the water, was until recently thought to cause chronic illness, but damage to the reproductive systems was slight.

A Danish study from Faculty of Life Sciences at the University of Copenhagen (LIFE; Copenhagen, Denmark), shows that what the parasite does is to lay eggs in the reproductive organs, resulting in chronic infection. This infection causes perforations or sores in the woman's uterine tissues. For many of the millions of women who have been repeatedly infected with the parasite, it is not actually possible to do anything once the damage has been done.

The field study, carried out on Madagascar, shows that the parasite also inflicts considerable damage to women's reproductive organs, making them particularly vulnerable to infection. There was a connection between the illness and infertility and though men are also infected, they have fewer symptoms than women do. The scientists revealed that there is an infectious reaction and saw that the infected cells are spread through the man's semen. The prevalence of schistosomiasis on the island is estimated as 2.5 million infected people.

Niels Ørnbjerg, D.Sc., director of Veterinary Disease Biology at LIFE, said, "We know that 200 million people are already infected with the parasite. What we did not know before now was that over the years the parasite causes sores in the woman's reproductive organs, which makes it easier for infections such as HIV to take hold.” Birgitte J. Vennervald, M.D., a senior researcher on the project said, "For many of the millions of women who have been repeatedly infected with the parasite, it is not actually possible to do anything once the damage has been done. However, the prospects look slightly brighter for younger women where the parasite has not yet disappeared from the body."

Early clinical manifestations of schistosomiasis are urticaria, fever and eosinophilia. Later, dysuria, hematuria and obstructive nephropathy or hepatosplenomegaly and portal hypertension may appear. Microscopic identification of eggs in stool or urine is the most practical method for diagnosis. Urinary form is often complicated by bladder cancer in advanced cases, as the parasite may survive for decades in human host. There are recurrent reports of outbreaks among immigrants and travelers who have been in infected water sources in the tropics.

Related Links:

University of Copenhagen




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.